Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Straumann TLX Implant System

K-Number: K200586 · 2020-08-20

Decision Date2020-08-20
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Straumann TLX Implant System is a medical device manufactured by Institut Straumann AG. It received FDA 510(k) clearance on 2020-08-20 under approval number K200586. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Straumann TLX Implant System?

Straumann TLX Implant System is a medical device that received FDA 510(k) clearance on 2020-08-20. It is manufactured by Institut Straumann AG. The 510(k) number is K200586.

When was Straumann TLX Implant System approved by the FDA?

Straumann TLX Implant System received FDA 510(k) clearance on 2020-08-20, under approval number K200586.

What company makes Straumann TLX Implant System?

Straumann TLX Implant System is manufactured by Institut Straumann AG.

What is the FDA product code for Straumann TLX Implant System?

The FDA product code for Straumann TLX Implant System is DZE.

Related Clinical Trials

Related PubMed Literature

Other Devices by Institut Straumann AG

View all 56 devices →

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.